ClinicalMetric / Countries / Finland / acute lymphoblastic leukemia in relapse
← 🇫🇮 Finland Trials
🇫🇮 Finland Country × Condition

acute lymphoblastic leukemia in relapse Clinical Trials in Finland

Active clinical trials for acute lymphoblastic leukemia in relapse with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇫🇮 Finland

Active Trials in Finland (1)

NCT05658640 Phase 1, Phase 2
Recruiting

HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies

Enrollment
26 pts
Country
🇫🇮 Finland
Princess Maxima Center for Pediatri...
View Trial →

Frequently Asked Questions

How many acute lymphoblastic leukemia in relapse clinical trials are active in Finland?
There are currently 1 active clinical trials for acute lymphoblastic leukemia in relapse with sites in Finland, of which 1 are actively recruiting patients.
How can I join a acute lymphoblastic leukemia in relapse clinical trial in Finland?
To join a acute lymphoblastic leukemia in relapse clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute lymphoblastic leukemia in relapse trials in Finland?
Active acute lymphoblastic leukemia in relapse trials in Finland span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Finland Trials → Global acute lymphoblastic leukemia in relapse Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology